H&R GmbH KGaA (WBO:2HRA) 1-Year Sharpe Ratio: N/A (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WBO:2HRA H&R GmbH & Co KGaA WBO:2HRA
47 GF Score
Price €7.02
GF Value €4.72
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is H&R GmbH KGaA 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-09-09), H&R GmbH KGaA's 1-Year Sharpe Ratio is Not available.

H&R GmbH KGaA  (WBO:2HRA) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

H&R GmbH KGaA 1-Year Sharpe Ratio Related Terms

WBO:2HRA vs LIN, SHW, ECL: 1-Year Sharpe Ratio Comparison

For the Specialty Chemicals subindustry, H&R GmbH KGaA's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

H&R GmbH KGaA 1-Year Sharpe Ratio vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, H&R GmbH KGaA's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where H&R GmbH KGaA's 1-Year Sharpe Ratio falls into.


WBO:2HRA
47GF Score
H&R GmbH & Co KGaA WBO:2HRA
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

H&R GmbH KGaA 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Is H&R GmbH KGaA (WBO:2HRA) Overvalued in 2026?

Based on GuruFocus' analysis, H&R GmbH KGaA stock appears to be overvalued. The current stock price of €7.02 is trading 48.7% above its estimated GF Value™ of €4.72. GuruFocus considers H&R GmbH KGaA to be Significantly Overvalued.

Key valuation signals for WBO:2HRA:

  • 1-Year Sharpe Ratio: N/A
  • GF Value™: €4.72 vs. price of €7.02 (48.7% above fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the WBO:2HRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

H&R GmbH KGaA Business Description

Other Exchanges 0RRC:UK2HRA:Germany
Address Neuenkirchener Strasse 8, Salzbergen, NI, DEU, 48499
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
47GF Score

Get the complete analysis for WBO:2HRA

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€7.02
Price
€4.72
GF Value